SCHEMBL2038087

SCHEMBL2038087

O=C(O)C1CCC(c2cccc(-c3ccccc3)c2)N1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.56
SCN3A Q9NY46 3/20 0.46
DPP4 P27487 1/20 0.43
CYP2C19 P33261 3/20 0.41
SLC6A3 Q01959 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
FABP7 O15540 1/20 0.40
FABP3 P05413 1/20 0.40
FABP5 Q01469 1/20 0.40
S1PR4 O95977 2/20 0.39
S1PR1 P21453 2/20 0.39
S1PR5 Q9H228 2/20 0.39
S1PR3 Q99500 1/20 0.39
KMO O15229 1/20 0.39
SLC5A2 P31639 1/20 0.38
GRIK1 P39086 1/20 0.38
GRIA2 P42262 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135105 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL197791 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL1226045 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL8513273 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL197425 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL135106 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL5696388 0.87 KCNH2 (0.56) KCNH2SCN3ADPP4CYP2C19S1PR4
SCHEMBL14635593 0.86 KCNH2 (0.52) KCNH2SCN3ADPP4SLC6A3
SCHEMBL14635594 0.86 KCNH2 (0.52) KCNH2SCN3ADPP4SLC6A3
Hydrochloric Acid SCHEMBL5513962 0.85 KCNH2 (0.55) KCNH2SCN3ADPP4CYP2C19S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513053-A1 PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43) Euroscreen S.A. (BE) 2012-10-24 EP disclosed
WO-2011073376-A1 PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43) EUROSCREEN S.A. (BE) 2011-06-23 WO disclosed